-transparent.png){kind=logo}
A novel basic heparin-binding monocyte chemotactic factor (MCF) was purified to homogeneity from the conditioned media of human myelomonocytic cell line THP-1 based on its in vitro monocyte chemotactic activity. The purified MCF was homogenous and estimated to be 15 kD on SDS-PAGE. Purified MCF stimulated normal human monocytes to be growth inhibitory in vitro at 2-3 d for several human tumor cell lines. This represents the first report of the identification and purification of a chemoattractant cytokine that also activates monocytes but is distinct from interferons and other known cytokines.
Related Publications
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
June 1990,
The Journal of experimental medicine,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
April 1988,
Journal of biochemistry,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
March 1981,
The Biochemical journal,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
January 1992,
Revista latinoamericana de microbiologia,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
April 1992,
International immunology,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
March 1989,
Journal of the National Cancer Institute,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
February 1986,
Molecular immunology,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
September 1991,
Zhonghua bing li xue za zhi = Chinese journal of pathology,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
March 1991,
Japanese journal of cancer research : Gann,
K Matsushima, and
C G Larsen, and
G C DuBois, and
J J Oppenheim
February 1992,
The Journal of experimental medicine,
